ENDRA Life Sciences (NDRA) EPS (Basic): 2016-2021
Historic EPS (Basic) for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$5.35.
- ENDRA Life Sciences' EPS (Basic) fell 2331.82% to -$5.35 in Q4 2021 from the same period last year, while for Dec 2021 it was -$5.55, marking a year-over-year decrease of 545.35%. This contributed to the annual value of -$21.43 for FY2024, which is 98.97% up from last year.
- Latest data reveals that ENDRA Life Sciences reported EPS (Basic) of -$5.35 as of Q4 2021, which was down 8,816.67% from -$0.06 recorded in Q3 2021.
- Over the past 5 years, ENDRA Life Sciences' EPS (Basic) peaked at -$0.06 during Q1 2021, and registered a low of -$5.35 during Q4 2021.
- Its 3-year average for EPS (Basic) is -$0.73, with a median of -$0.26 in 2020.
- As far as peak fluctuations go, ENDRA Life Sciences' EPS (Basic) soared by 82.96% in 2017, and later crashed by 2,331.82% in 2021.
- ENDRA Life Sciences' EPS (Basic) (Quarterly) stood at -$0.65 in 2017, then skyrocketed by 56.92% to -$0.28 in 2018, then plummeted by 328.57% to -$1.20 in 2019, then spiked by 81.67% to -$0.22 in 2020, then slumped by 2,331.82% to -$5.35 in 2021.
- Its EPS (Basic) stands at -$5.35 for Q4 2021, versus -$0.06 for Q3 2021 and -$0.08 for Q2 2021.